Novartis shares climb on strong Cosentyx sales, franchise growth, and a new malaria drug approval despite political risks.

Nurix Therapeutics shows strong BTK degrader data and key pharma ties, with risks but solid long-term potential. Find out why ...

Micron Technology, Inc. (NASDAQ:MU) is one of the best large-cap stocks to buy right now. On June 26, Baird increased its ...

A Wall Street maxim states, “Twenty percent of investors who want to make money are in stocks, while the other 80 percent who ...

Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...

Donald Trump's proposed 200% tariffs can squeeze the profit margins of pharma companies, but LLY is poised to "benefit" ...

Shares of Performance Food Group climbed after Bloomberg reported that U.S. Foods has been evaluating an acquisition of the food distribution company. The stock gained 7.6%, to $97.27, in premarket ...

Buying shares of beaten-down companies only makes sense if there are good reasons to expect them to bounce back. If that's not the case, stocks that may look cheap and attractive aren't actually so.

Pfizer faces adjusted financial forecasts as analysts lower earnings expectations for FY2025, signaling cautious optimism.

Pfizer is expected to announce its second-quarter results next month, and analysts predict a single-digit drop in the company ...

Johnson & Johnson JNJ and Pfizer PFE rank among the world’s largest pharmaceutical companies, each with broad and diversified ...